Amino Acids
drugOn this page
Also known as .alpha.-amino acidsAmino acids 11.4%Amino acids 15%Amino acids 20%Amino acids 4%Amino acids 5%Amino acids 5.4%Amino acids 6%Amino acids 6.5%Amino acids 6.9%Amino acids 8%Amino acids component of procalamineAmino acids nossource unspecifiedL-.alpha.-amino acidsL-amino acidsRenamin w/o electrolytesTrophamine
Summary
Amino Acids (CHEMBL1201498) is an approved unknown (ATC B05BA01); indicated across 9 conditions including kidney failure and muscular atrophy.
At a glance
- Status: Approved (max clinical phase 4)
- Modality: Unknown
- ATC class: B05BA01
- Indications: 9 conditions
- Clinical trials: 25
Identifiers
Drug identity and classification
| Field | Value |
|---|---|
| ChEMBL ID | CHEMBL1201498 |
| Name | Amino Acids |
| Type | Unknown |
| Max phase | 4 |
| ATC | B05BA01 |
Also known as: .alpha.-amino acids, Amino acids, Amino acids 11.4%, Amino acids 15%, Amino acids 20%, Amino acids 4%, Amino acids 5%, Amino acids 5.4%, Amino acids 6%, Amino acids 6.5%, Amino acids 6.9%, Amino acids 8%
Targets
Targets
No target linkage available.
Bioactivity
No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).
Target pathways
No target-pathway data for this drug (no mapped target genes).
Indications & clinical
Indications
9 indications (0 at ChEMBL trial phase 4). Phase below is the highest clinical-trial phase recorded for this drug against each disease — not the molecule’s overall approval status (that is in the Summary).
| Indication | Trial phase | MONDO | EFO |
|---|---|---|---|
| kidney failure | 2 | MONDO:0001106 | EFO:1002048 |
| muscular atrophy | 2 | MONDO:0004323 | EFO:0009851 |
| severe acute respiratory syndrome | 2 | MONDO:0005091 | MONDO:0100096 |
| glioma | 2 | MONDO:0021042 | MONDO:0100342 |
| neuroendocrine neoplasm | 1 | MONDO:0019496 | EFO:1001901 |
| injury | 0 | MONDO:0021178 | EFO:0000546 |
3 further indication records had no mapped disease name (EFO/MeSH-only) or were duplicates, and are omitted.
Clinical trials
Total trials: 25.
Phase distribution
| Phase | Trials |
|---|---|
| Not specified | 20 |
| PHASE2 | 3 |
| PHASE3 | 1 |
| PHASE1 | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT03709264 | PHASE3 | COMPLETED | Intravenous Amino Acid Therapy for Kidney Protection in Cardiac Surgery. |
| NCT07001098 | PHASE2 | NOT_YET_RECRUITING | Amino Acids for Cardiac Surgery Associated AKI |
| NCT03013387 | PHASE2 | WITHDRAWN | Dosimetry Guided PRRT With 90Y-DOTATOC |
| NCT03273712 | PHASE2 | COMPLETED | Dosimetry-Guided, Peptide Receptor Radiotherapy (PRRT) With 90Y-DOTA- tyr3-Octreotide (90Y-DOTATOC) |
| NCT00872911 | PHASE1 | COMPLETED | Nutrition and Exercise for Sarcopenia |
| NCT07422792 | Not specified | RECRUITING | Anabolic Response To Intravenous Amino Acids In Chronic Intestinal Failure Patients |
| NCT00005889 | Not specified | UNKNOWN | Gluconeogenesis in Very Low Birth Weight Infants Who Are Receiving Nutrition By Intravenous Infusion |
| NCT00557388 | Not specified | COMPLETED | Dietary Strategies to Promote Muscle Protein Anabolism in the Elderly |
| NCT00614133 | Not specified | COMPLETED | Effect of Intravenous Nutrition and Epidural Analgesia on Protein Loss After Surgery |
| NCT00714675 | Not specified | COMPLETED | Citrulline and Protein Metabolism in the Malnourished Elderly People |
| NCT01150188 | Not specified | COMPLETED | Effects of Amino Acids on Regional Lipid Metabolism |
| NCT01208324 | Not specified | COMPLETED | Estrogen and Serotonin on Changing Brain Chemistry |
| NCT01414946 | Not specified | COMPLETED | The Effect of Intravenous Nutrition in Patients Undergoing Abdominal Surgery |
| NCT01495871 | Not specified | WITHDRAWN | Amino Acid Supplementation in Recovery From Traumatic Brain Injury |
| NCT01860573 | Not specified | COMPLETED | Neurodevelopmental and Growth Outcomes of Early, Aggressive Protein Intake in Very Low Birthweight Infants |
| NCT02370745 | Not specified | COMPLETED | Characterizing the Incretin Effect of Amino Acids and Defining GLP-1 Role on Skeletal Muscle |
| NCT02487680 | Not specified | COMPLETED | Effects of an Amino Acid and Chromium-picolinate Containing Drink on Glucose Metabolism on Healthy Subjects |
| NCT02549443 | Not specified | COMPLETED | The Anabolic Effect Of Perioperative Nutrition With Insulin In Patients Undergoing CABG |
| NCT02894931 | Not specified | UNKNOWN | Effects of Dietary Interventions on Serum and Macrophage Atherogenicity |
| NCT03539809 | Not specified | COMPLETED | Branched Chain Amino Acids Ratio in Medical Foods |
| NCT03644836 | Not specified | COMPLETED | Interest of Branched Chain Amino Acids Associated With a Respiratory Rehabilitation Program in Patients Broncho Chronic Obstructive Pulmonary Disease |
| NCT04064528 | Not specified | COMPLETED | Effects of Age on Amino Acid Delivery to Tendon |
| NCT04067479 | Not specified | COMPLETED | Can Amino Acid Supplementation Augment the Anabolic Response in Tendon After Exercise |
| NCT04425642 | Not specified | COMPLETED | Effects of Parenteral Nutrition in HSCT |
| NCT05971563 | Not specified | COMPLETED | Amino Acid Kinetics of GMP-AA in Healthy Human Volunteers |
Clinical evidence (CIViC)
No CIViC predictive evidence (expected for non-precision-medicine drugs).
Pharmacology
Pharmacogenomics
No PharmGKB pharmacogenomic data curated for this drug.
Related molecules
Related molecules
No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.